Octagon Capital Advisors as of Dec. 31, 2020
Portfolio Holdings for Octagon Capital Advisors
Octagon Capital Advisors holds 31 positions in its portfolio as reported in the December 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Apellis Pharmaceuticals (APLS) | 10.9 | $31M | 548k | 57.20 | |
| I Mab Sponsored Ads (IMAB) | 7.4 | $21M | 455k | 47.15 | |
| Celldex Therapeutics Com New (CLDX) | 6.3 | $18M | 1.0M | 17.52 | |
| Curis Com New | 6.2 | $18M | 2.2M | 8.19 | |
| 4d Molecular Therapeutics In (FDMT) | 5.4 | $16M | 378k | 41.45 | |
| Pmv Pharmaceuticals (PMVP) | 5.3 | $15M | 250k | 61.51 | |
| Arvinas Ord (ARVN) | 5.3 | $15M | 179k | 84.93 | |
| Gossamer Bio (GOSS) | 5.2 | $15M | 1.6M | 9.67 | |
| Acceleron Pharma | 5.0 | $14M | 112k | 127.94 | |
| Chemocentryx | 4.8 | $14M | 225k | 61.92 | |
| Cardiff Oncology (CRDF) | 4.1 | $12M | 650k | 17.99 | |
| Avidity Biosciences Ord (RNA) | 3.8 | $11M | 430k | 25.52 | |
| Dyne Therapeutics (DYN) | 3.5 | $10M | 482k | 21.00 | |
| Taysha Gene Therapies Com Shs (TSHA) | 2.9 | $8.5M | 320k | 26.54 | |
| Arcus Biosciences Incorporated (RCUS) | 2.7 | $7.8M | 300k | 25.96 | |
| Calliditas Therapeutics Ab Sponsered Ads (CALT) | 2.3 | $6.7M | 200k | 33.62 | |
| Fibrogen (FGEN) | 1.9 | $5.4M | 146k | 37.09 | |
| Kiniksa Pharmaceuticals Com Cl A (KNSA) | 1.8 | $5.2M | 295k | 17.67 | |
| Revolution Medicines (RVMD) | 1.7 | $5.0M | 126k | 39.59 | |
| Kura Oncology (KURA) | 1.7 | $4.9M | 150k | 32.66 | |
| Iveric Bio | 1.6 | $4.7M | 680k | 6.91 | |
| Helix Acquisition Corp Com Cl A | 1.6 | $4.5M | 400k | 11.37 | |
| Kronos Bio (KRON) | 1.5 | $4.4M | 146k | 29.87 | |
| Jiya Acquisition Corp Com Cl A | 1.1 | $3.1M | 300k | 10.30 | |
| Viela Bio | 1.1 | $3.1M | 85k | 35.97 | |
| Inventiva Sa Ads (IVA) | 1.0 | $2.9M | 200k | 14.50 | |
| Arcutis Biotherapeutics (ARQT) | 1.0 | $2.8M | 100k | 28.13 | |
| Ngm Biopharmaceuticals (NGM) | 0.8 | $2.3M | 75k | 30.30 | |
| Aclaris Therapeutics (ACRS) | 0.8 | $2.3M | 350k | 6.47 | |
| Kadmon Hldgs | 0.6 | $1.8M | 434k | 4.15 | |
| Axsome Therapeutics (AXSM) | 0.6 | $1.6M | 20k | 81.45 |
